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Amongst the advanced cardiac imaging modalities,
multi detector computed tomography coronary angi-
ography (CTCA) has emerged as a reliable non-
invasive method for the assessment of coronary
anatomy,coronaryarterydisease,andcardiacfunction
[1–16]. Multiple studies involving over several
thousands of patients have established that CTCA is
highly accurate for delineation of the presence and
severity of coronary atherosclerosis [9, 17–29]. CTCA
may also reveal the total plaque burden, i.e., both
calciﬁed and non-calciﬁed components, for individual
patients with coronary atherosclerosis [30–39].
The advent of prospectively gated acquisition
techniquesfor64-sliceCTCAhasallowedasigniﬁcant
reduction in dose exposure [40–43]. Consequently, a
combined approach of CTCA and myocardial perfu-
sion imaging with CTCA angiography might poten-
tially become feasible at a total radiation dose of much
less than 10 mSv, particularly for the assessment of
patients with established coronary artery disease, who
are likely to have diffuse calciﬁcation [44–52]. In
routine CTCA acquisitions, there might be a
considerable signal density drop at the posterobasal
wall resembling perfusion defects possibly being
attributed to beam hardening artifacts [53]B e a m
hardeningartifactsmaybeacommonﬁndingatCTCA
of asymptomatic patients affecting predominantly the
posterobasal wall, reducing the accuracy of CTCA.
Also coronary vessel attenuation may affect the
accuracy of CTCA as for an accurate detection of
coronary plaque an appropriate amount of contrast
materialisneeded.Coronarybloomingartifactscaused
bytoolargecontractmaterialamountsmayhamperthe
detection of coronary plaque. The attenuation of
coronary vessels is inﬂuenced by the individual
patient’s weight and height which are expressed by
body mass index and body surface area (BSA)
Attenuation of coronary vessels in CTCA is closely
relatedtoseveralfactorsincludingbothpatientspeciﬁc
characteristics such as body mass, blood volume and
cardiac outputandprotocol-related parameterssuchas
concentration and injection rate of the administered
contrast material.
In patients with increased body mass CTCA image
quality is degraded by an unfavorable shift in the
signal-to-noise ratio due to increase in noise and loss
of attenuation. Introduction of scan protocols with
body mass index-adapted tube current and voltage
have allowed handling the adverse effects of body
mass on image noise. Therefore, BSA would be the
most promising parameter to be used for contrast
protocol adjustment. An ideal protocol should inte-
grate both body mass index adaptation of tube
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rial adjustment according to BSA (signal optimiza-
tion). This may help differentiating coronary plaque
from surrounding tissue and avoid blooming artifacts
caused by intracoronary contrast material concentra-
tion. In patients with a large total blood volume,
contrast material dilution decreases coronary attenu-
ation in CTCA. In addition, increased blood volume
is well paralleled by BSA.
In the current issue of the International Journal of
CardiovascularImaging,Pazhenkottiletal.[54],using
low-dose CTCA with prospective ECG-triggering,
evaluated a BSA-adapted contrast material pro-
tocol to compensate for dilution effects in 80 patients
with a BSA-adapted contrast material bolus ranging
40–105 ml and injection rate ranging 3.5–5.0 ml/s for
aBSAof\1.70 m
2toC2.50 m
2.Atotalof80controls
matched for BSA who had previously undergone
routine CTCA with a ﬁxed contrast material protocol
of 80 ml at 5 ml/s served as reference group. The
average vessel attenuation from both the proximal
right coronary artery and the left main coronary artery
was assessed. Correlation of BSA with vessel atten-
uation was assessed in both groups. Interestingly, the
authorsfoundthatBSA-matchingwassuccessfulinall
patients (BSA-adapted group 1.98 ± 0.15 m
2 versus
the reference group 1.98 ± 0.17 m
2). Mean contrast
material bolus was signiﬁcantly smaller in the BSA-
adapted versus the reference group (mean 70 ml vs.
mean 80 ml). There was no correlation in the BSA-
adapted group, while coronary attenuation was signif-
icantlyinverselyrelatedtoBSAinthereferencegroup.
It was concluded that a BSA-adapted contrast material
protocol successfully results in a comparable coronary
contrast enhancement independent of individual BSA.
Thiswasachieveddespiteasigniﬁcantreductioninthe
overall contrast material amount. The ﬁndings of the
present study therefore clearly show that the BSA-
adapted contrast material administration protocol is
feasible and successful as the inverse correlation
between BSA and coronary attenuation found in the
control group could be abolished. As a result, range
and standard deviation of coronary attenuation were
smaller in the BSA-adapted group compared to the
control group, indicating a well-balanced consistent
contrast enhancement throughout a large range of
BSA. Furthermore, by using the BSA-adapted proto-
col a signiﬁcantly lower average amount of contrast
medium was injected, which may help preventing
contrast induced nephropathy and its consequences.
Previous studies [55–58] from the same group
directed by Kaufmann had already shown that the use
of the proposed body mass index-adapted scanning
parameters results in similar image noise regardless
of body mass index. Tatsugami et al. [55] initially
showed that an increased bolus dilution due to larger
blood volume may account for the decrease in
contrast-to-noise ratio and vessel attenuation in
patients with higher body mass index, but in this
study the contrast bolus was not adapted to body mass
index. Herzog et al. [56] showed that, after success-
fully overcoming the impact of body mass index on
image noise by adapting tube parameters, the contrast
to noise ratio mainly depends on coronary vessel
contrast. The latter reﬂects the dilution of the contrast
material by blood volume and cardiac output, which
are both correlated to BSA. Therefore, BSA-adapted
contrast administration may help to compensate for
this effect. Husman et al. [57, 58] recently reported
that a BMI-adapted contrast material protocol results
in adequate coronary vessel attenuation independent
of individual body mass index despite a signiﬁcant
reduction in overall amount of contrast material used.
To summarize, the current study validly extends
previous ﬁndings that the proposed BSA-adapted
contrast material protocol in patients undergoing low-
dose CTCA results in adequate coronary vessel
attenuation independent of individual BSA.
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